Bodytrak awarded trial contract with US Department of Defense
Bodytrak will be used to track, predict and detect crucial physiological functions of fixed wing pilots in the US Navy to improve health and wellbeing.
Courtesy Bodytrak
Bodytrak today announced that the Defense Innovation Unit, through the Army Contracting Command, has awarded Bodytrak a contract to trial its cutting-edge in-ear physiological monitoring technology with US Navy’s fixed wing pilots.
The trial will demonstrate how wearable physiological monitoring technology can help reduce the number of physiological incidents during or after a flight that pose a significant health and safety threat to personnel and contribute to aircrew deaths and aircraft losses. The aim is to prove the benefits of such technology in a controlled environment, deploy pilot tests in flight and accelerate new innovation into the US department of defence - and into the hands of defence personnel.
Bodytrak, which sits unobtrusively in the ear, tracks a range of vital signs accurately and in real time to prevent negative physiological incidents. If an abnormality is detected, an audible alert is provided to the wearer and/or a control centre, acting as an early warning signal to initiate a rapid intervention, resulting in the prevention of a major injury and saving costly resources.
Leon Marsh, CEO and Founder of Bodytrak said: “We are delighted to have been selected as a preferred supplier to the US Department of Defense to trial Bodytrak with the intent of mitigating the present safety risks that fast jet pilots can experience, and provide a key contribution to preventing the associated loss of personnel and aircraft.”
